This had to happen at some stage. You can't have a company like IMU ticking boxes with enlightened and innovative treatments for one of the deadliest diseases to mankind and then being ignored
Someone here once said (maybe several times) that the science will speak for itself.
Large companies like Merck and Pfizer "dipping their toes" in is a really good sign that they are interested in IMU's progress - and future.
Next 12 months will get very interesting in this space - it won't take years.
Ann: Clinical Trial Supply Agreement with Merck KGaA and Pfizer, page-113
-
- There are more pages in this discussion • 140 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
-0.001(0.85%) |
Mkt cap ! $440.9M | |||
| Open | High | Low | Value | Volume |
| 6.0¢ | 6.2¢ | 5.8¢ | $1.284M | 21.33M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 1363702 | 5.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.9¢ | 318064 | 21 |
View Market Depth
| Last trade - 11.55am 15/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |